ACOR - Acorda Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue471,433588,287519,601492,660
Cost of Revenue99,310135,714108,10992,931
Gross Profit372,123452,573411,492399,729
Operating Expenses
Research Development105,183160,605203,437149,209
Selling General and Administrative172,154178,919217,837205,230
Non Recurring----
Others----
Total Operating Expenses376,647475,238529,383447,370
Operating Income or Loss94,786113,049-9,78245,290
Income from Continuing Operations
Total Other Income/Expenses Net-74,363-364,934-32,486-25,921
Earnings Before Interest and Taxes94,786113,049-9,78245,290
Interest Expense-21,597-18,664-16,527-15,472
Income Before Tax20,423-251,885-42,26819,369
Income Tax Expense-13,259-28,526-6,6658,311
Minority Interest----
Net Income From Continuing Ops33,682-223,359-35,60311,058
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income33,682-223,359-34,61811,058
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares33,682-223,359-34,61811,058